Integrating Site-specific Peptide Reporters and Targeted Mass Spectrometry Enables Rapid Substrate-specific Kinase Assay at the Nanogram Cell Level
2021
Abstract Dysregulation of phosphorylation-mediated signaling drives the initiation and progression of many diseases. A substrate-specific kinase assay capable of quantifying the altered site-specific phosphorylation of its phenotype-dependent substrates provides better specificity to monitor a disease state. We report a sensitive and rapid substrate-specific kinase assay by integrating site-specific peptide reporter and multiple reaction monitoring (MRM)-MS platform for relative and absolute quantification of substrate-specific kinase activity at the sensitivity of nanomolar kinase and nanogram cell lysate. Using non-small cell lung cancer as a proof-of-concept, three substrate peptides selected from constitutive phosphorylation in tumors (HDGF-S165, RALY-S135, and NRD1-S94) were designed to demonstrate the feasibility. The assay showed good accuracy (
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
52
References
0
Citations
NaN
KQI